Your browser doesn't support javascript.
loading
Increased Motility and Suppression of Ex Vivo-Expanded Regulatory T Cells Designed for Adoptive Transfer Therapy in Ulcerative Colitis.
Müller, Tanja M; Liu, Li-Juan; Czerwinski, Tina; Wiesinger, Manuel; Dedden, Mark; Paap, Eva-Maria; Ullrich, Karen A-M; Atreya, Imke; Siegmund, Britta; Atreya, Raja; Fabry, Ben; Berking, Carola; Neurath, Markus F; Zundler, Sebastian; Voskens, Caroline J.
Afiliação
  • Müller TM; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany.
  • Liu LJ; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Czerwinski T; Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Wiesinger M; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Dedden M; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Paap EM; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Ullrich KA; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Atreya I; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany.
  • Siegmund B; Medical Department, Division of Gastroenterology, Infectiology and Rheumatology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
  • Atreya R; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany.
  • Fabry B; Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Berking C; Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Neurath MF; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany.
  • Zundler S; Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany. Electronic address: sebastian.zundler@uk-erlangen.de.
  • Voskens CJ; Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Erlangen, Germany; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: caroline.bosch-voskens@uk-erlangen.de.
Cell Mol Gastroenterol Hepatol ; 16(1): 183-187.e2, 2023.
Article em En | MEDLINE | ID: mdl-37085136

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Linfócitos T Reguladores Limite: Animals Idioma: En Revista: Cell Mol Gastroenterol Hepatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Linfócitos T Reguladores Limite: Animals Idioma: En Revista: Cell Mol Gastroenterol Hepatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
...